Concepedia
Statistics
Publications
11
Citations
601
H-Index
10
Active since
1981
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
R. S. Gelman is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and pharmacology.
Publications per year
1981–2011
Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer
Abram Recht, William Silen, Stuart J. Schnitt et al. · International Journal of Radiation Oncology*Biology*Physics · 1988 · 219 citations
Medicine, Oncology, Surgery +16
A phase II trial of the PARP inhibitor veliparib (ABT888) and temozolomide for metastatic breast cancer.
SJ Isakoff, Beth Overmoyer, Nadine Tung et al. · Journal of Clinical Oncology · 2010 · 151 citations
Medicine, Oncology, Pharmacology +16
Neoadjuvant cisplatin and bevacizumab in triple negative breast cancer (TNBC): Safety and efficacy
Paula D. Ryan, Nadine Tung, SJ Isakoff et al. · Journal of Clinical Oncology · 2009 · 83 citations
Medicine, Oncology, Pharmacology +14
Prolonged disease-free survival in advanced breast cancer treated with "super-CMF" adriamycin: an alternating regimen employing high-dose methotrexate with citrovorum factor rescue.
Henderson Ic, R. S. Gelman, Canellos Gp et al. · PubMed · 1981 · 28 citations
Medicine, Oncology, Pharmacology +15
Mammography in Symptomatic and Asymptomatic Patients
Paul C. Stomper, R. S. Gelman · Hematology/Oncology Clinics of North America · 1989 · 26 citations
Medicine, Radiology, Cancer Screening +11
1–5 of 11